The concurrent decrease in IFNγ and IL-8 further supports a defective Th1-mediated effector function and impaired inflammatory signaling, indicating a shift from protective anti-tumor immunity toward chronic, dysregulated inflammation. The gene discussed is CXCL8; the disease is neoplasm.